Clinical Trial Update: Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1 [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating hexaminolevulinate (HAL) photodynamic therapy for cervical intraepithelial neoplasia grade 1 has been terminated, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Hexaminolevulinate (HAL) photodynamic therapy (hexaminolevulinate)

Snippet

Sponsor: Photocure | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: TERMINATED | Results posted: 2013-04-15